Funder: INDUSTRIAL FARMACEUTICA CANTABRIA S.A.
date_range Duration: from 28 June 2019 to 13 June 2022 (36 months) Finished

Of National scope. It has been granted under a regime of Direct grant.

Call: (INDUSTRIAL FARMACEUTICA CANTABRIA S.A.)

Researchers